Cargando…
Why Do We Screen Newborn Infants for Cystic Fibrosis?
Autores principales: | Barben, Jürg, Southern, Kevin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570329/ https://www.ncbi.nlm.nih.gov/pubmed/33123637 http://dx.doi.org/10.3390/ijns6030056 |
Ejemplares similares
-
International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis
por: Chudleigh, Jane, et al.
Publicado: (2022) -
Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
por: Armstrong, Rachael E., et al.
Publicado: (2020) -
Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study
por: Johnson, Faye, et al.
Publicado: (2019) -
Processing Newborn Bloodspot Screening Results for CF
por: Barben, Jürg, et al.
Publicado: (2020) -
Factors affecting the growth of infants diagnosed with cystic fibrosis by newborn screening
por: Patterson, K. D., et al.
Publicado: (2019)